SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.
SynaptixBio has raised $2.6M in total funding. The most recent round was Grant. The last funding was announced in August 2024.
SynaptixBio's investors include Innovate UK.
SynaptixBio is headquartered in Oxford, United Kingdom.
SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.
SynaptixBio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SynaptixBio — Funding & Investors." VCBacked, August 22, 2024, https://www.vcbacked.co/company/synaptixbio. Accessed August 14, 2026.
VCBacked. (2024). SynaptixBio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/synaptixbio
{{cite web |title=SynaptixBio — Funding & Investors |url=https://www.vcbacked.co/company/synaptixbio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated